Background & Objective
Alzheimer’s is often not diagnosed until symptoms are already noticeable. MultiDiag aims to use blood biomarkers to detect the disease years before clinical onset.
At its heart is a fully automated benchtop platform which, for the first time, combines three types of assay (DNA PCR, RNA PCR and protein immunoassay) without the need to change equipment. Samples in, results out.
Highlights
- Development of the mechanical automation platform
- Integration of immunoprecipitation and real-time PCR into a single workflow
- Fully automated sample-to-result processing with no manual steps
- Parallel analysis: Alzheimer’s biomarkers and hepatitis multi-markers
- System validation and preparation for regulatory approval
Project partners
EDC
Roboscreen
Project details
| Type | Funded project |
| Status | Ongoing |
| Duration | 01.10.2023 – 30.09.2026 |
| Funding body | Sächsische Aufbaubank - Development Bank - SAB |
| Funding code | 100710308 |
| Partners | Roboscreen, EDC Engineering |
Funding body
